EXOSC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.435850E-01
Normal-vs-Stage2
2.910400E-01
Normal-vs-Stage3
7.299200E-01
Normal-vs-Stage4
1.488570E-01
Stage1-vs-Stage2
8.008000E-01
Stage1-vs-Stage3
3.687400E-01
Stage1-vs-Stage4
4.703000E-01
Stage2-vs-Stage3
4.487800E-01
Stage2-vs-Stage4
2.540400E-01
Stage3-vs-Stage4
6.797600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.675200E-01
Normal-vs-AfricanAmerican
8.376600E-01
Normal-vs-Asian
8.654100E-02
Caucasian-vs-AfricanAmerican
1.662370E-01
Caucasian-vs-Asian
2.598000E-02
AfricanAmerican-vs-Asian
2.573800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.832400E-01
Normal-vs-Female
2.666800E-01
Male-vs-Female
8.613200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.672350E-01
Normal-vs-Age(41-60Yrs)
3.335200E-01
Normal-vs-Age(61-80Yrs)
2.685800E-01
Normal-vs-Age(81-100Yrs)
1.879410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.189200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.696200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.603000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.861200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.688200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.539840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.924600E-01
Normal-vs-Daily Drinker
1.638020E-01
Normal-vs-Weekly Drinker
1.570790E-01
Normal-vs-Occasional Drinker
1.300160E-01
Normal-vs-Social Drinker
3.605800E-01
Non Drinker-vs-Daily Drinker
1.799430E-01
Non Drinker-vs-Weekly Drinker
1.682400E-01
Non Drinker-vs-Occasional Drinker
2.960400E-01
Non Drinker-vs-Social Drinker
4.213600E-01
Daily Drinker-vs-Weekly Drinker
8.692000E-01
Daily Drinker-vs-Occasional Drinker
7.645200E-01
Daily Drinker-vs-Social Drinker
4.634100E-02
Weekly Drinker-vs-Occasional Drinker
6.557600E-01
Weekly Drinker-vs-Social Drinker
7.086000E-02
Occasional Drinker-vs-Social Drinker
8.140100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.091600E-01
Normal-vs-Grade 2
2.792200E-01
Normal-vs-Grade 3
6.847000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.921200E-01
Grade 1-vs-Grade 3
5.520800E-01
Grade 1-vs-Grade 4
6.091600E-01
Grade 2-vs-Grade 3
1.454350E-01
Grade 2-vs-Grade 4
2.792200E-01
Grade 3-vs-Grade 4
6.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.521400E-01
Normal-vs-NonDiabetic
2.136600E-01
Diabetic-vs-NonDiabetic
7.493600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.635800E-02
Normal-vs-NoPancreatitis
2.430800E-01
Pancreatitis-vs-NoPancreatitis
1.987170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.151400E-01
Normal-vs-N1
3.128600E-01
N0-vs-N1
2.550600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.759170E-01
Normal-vs-TP53-NonMutant
5.709200E-01
TP53-Mutant-vs-TP53-NonMutant
5.782700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
